250 results
Page 3 of 13
8-K
EX-99.1
7oe4rok1syrtlqeqh6jf
28 Sep 20
Idera Pharmaceuticals Announces New U.S. Patent Coverage for Tilsotolimod Through September 2037
8:50am
424B5
nylnhtos
3 Sep 20
Prospectus supplement for primary offering
8:26am
424B5
7ac618 rz
2 Sep 20
Prospectus supplement for primary offering
5:20pm
8-K
EX-99.1
fcagq0
4 Aug 20
Idera Pharmaceuticals Reports Second Quarter Financial Results and Provides Corporate Update
4:31pm
8-K
EX-99.1
g4rlu
15 Jul 20
Idera Pharmaceuticals Announces Private Placement of up to $20.0 Million
8:15am
8-K
EX-99.1
20ve 7v1oqwpe3ayi
2 Jun 20
Regulation FD Disclosure
8:33am
8-K
EX-99.1
boymctw tv7j4ixz0ibc
1 May 20
Idera Pharmaceuticals Reports First Quarter Financial Results and Provides Corporate Update
8:10am
8-K
EX-99.1
bb9ps91h
21 Apr 20
Idera Pharmaceuticals Announces Final Clinical Safety and Efficacy Data from ILLUMINATE-204 Trial in Advanced Melanoma
8:00am
8-K
EX-99.1
0rym8 iwibhr9n
7 Apr 20
Idera Pharmaceuticals Announces Private Placement of up to $20.7 Million
4:30pm
8-K
EX-99.1
i6wdw377
12 Mar 20
Idera Pharmaceuticals Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Corporate Update
7:49am
8-K
EX-99.1
9vih79kaqomodd
5 Mar 20
Regulation FD Disclosure
8:00am